NCT00346983View on ClinicalTrials.gov

Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

May 31, 2007

Conditions
Cystoid Macular Edema
Interventions
DRUG

Pegaptanib sodium

0.3mg/0.1ml intravitreal injection, every 6 weeks, up to a total of 3 injections

DRUG

Control

Sham injection, every 6 weeks, up to a total of 3 sham injections

Trial Locations (1)

21287

The Johns Hopkins Hospital, Baltimore

Sponsors

Collaborators (1)

Eyetech Pharmaceuticals
All Listed Sponsors
collaborator

Eyetech Pharmaceuticals

INDUSTRY

lead

Johns Hopkins University

OTHER